vs
Chord Energy Corp（CHRD）与瑞思迈（RMD）财务数据对比。点击上方公司名可切换其他公司
瑞思迈的季度营收约是Chord Energy Corp的1.2倍（$1.4B vs $1.2B），瑞思迈净利率更高（27.6% vs 7.2%，领先20.4%），瑞思迈同比增速更快（11.0% vs -19.6%），过去两年瑞思迈的营收复合增速更高（9.0% vs 3.8%）
Chord Energy Corp（前身为绿洲石油）是一家从事油气勘探、水力压裂业务的能源企业，核心运营区域位于美国北达科他州与蒙大拿州的威利斯顿盆地，注册地为特拉华州，总部设在得克萨斯州休斯敦，在北达科他州威利斯顿设有办事处。
瑞思迈是一家起源于澳大利亚、总部位于美国加利福尼亚州圣迭戈的医疗设备企业，主打可接入云端的呼吸类医疗设备，用于治疗睡眠呼吸暂停、慢性阻塞性肺病等呼吸道疾病，新冠疫情期间曾大量生产呼吸机等设备助力患者救治。
CHRD vs RMD — 直观对比
营收规模更大
RMD
是对方的1.2倍
$1.2B
营收增速更快
RMD
高出30.6%
-19.6%
净利率更高
RMD
高出20.4%
7.2%
两年增速更快
RMD
近两年复合增速
3.8%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $1.2B | $1.4B |
| 净利润 | $84.4M | $392.6M |
| 毛利率 | — | 61.8% |
| 营业利润率 | 7.9% | 34.6% |
| 净利率 | 7.2% | 27.6% |
| 营收同比 | -19.6% | 11.0% |
| 净利润同比 | -59.9% | 13.9% |
| 每股收益（稀释后） | $1.59 | $2.68 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CHRDRMD
| Q4 25 | $1.2B | $1.4B | ||
| Q3 25 | $1.3B | $1.3B | ||
| Q2 25 | $1.2B | $1.3B | ||
| Q1 25 | $1.2B | $1.3B | ||
| Q4 24 | $1.5B | $1.3B | ||
| Q3 24 | $1.5B | $1.2B | ||
| Q2 24 | $1.3B | $1.2B | ||
| Q1 24 | $1.1B | $1.2B |
净利润CHRDRMD
| Q4 25 | $84.4M | $392.6M | ||
| Q3 25 | $130.1M | $348.5M | ||
| Q2 25 | $-389.9M | $379.7M | ||
| Q1 25 | $219.8M | $365.0M | ||
| Q4 24 | $210.6M | $344.6M | ||
| Q3 24 | $225.3M | $311.4M | ||
| Q2 24 | $213.4M | $292.2M | ||
| Q1 24 | $199.4M | $300.5M |
毛利率CHRDRMD
| Q4 25 | — | 61.8% | ||
| Q3 25 | 74.0% | 61.5% | ||
| Q2 25 | — | 60.8% | ||
| Q1 25 | — | 59.3% | ||
| Q4 24 | — | 58.6% | ||
| Q3 24 | 77.3% | 58.6% | ||
| Q2 24 | — | 58.5% | ||
| Q1 24 | — | 57.9% |
营业利润率CHRDRMD
| Q4 25 | 7.9% | 34.6% | ||
| Q3 25 | 13.0% | 33.4% | ||
| Q2 25 | -34.2% | 33.7% | ||
| Q1 25 | 27.8% | 33.0% | ||
| Q4 24 | 18.2% | 32.5% | ||
| Q3 24 | 18.8% | 31.6% | ||
| Q2 24 | 22.9% | 31.2% | ||
| Q1 24 | 25.1% | 31.3% |
净利率CHRDRMD
| Q4 25 | 7.2% | 27.6% | ||
| Q3 25 | 9.9% | 26.1% | ||
| Q2 25 | -33.0% | 28.2% | ||
| Q1 25 | 18.1% | 28.3% | ||
| Q4 24 | 14.5% | 26.9% | ||
| Q3 24 | 15.5% | 25.4% | ||
| Q2 24 | 16.9% | 23.9% | ||
| Q1 24 | 18.4% | 25.1% |
每股收益（稀释后）CHRDRMD
| Q4 25 | $1.59 | $2.68 | ||
| Q3 25 | $2.26 | $2.37 | ||
| Q2 25 | $-6.77 | $2.58 | ||
| Q1 25 | $3.66 | $2.48 | ||
| Q4 24 | $3.53 | $2.34 | ||
| Q3 24 | $3.59 | $2.11 | ||
| Q2 24 | $4.25 | $1.97 | ||
| Q1 24 | $4.65 | $2.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $189.5M | $1.4B |
| 总债务越低越好 | $1.5B | $403.9M |
| 股东权益账面价值 | $8.1B | $6.3B |
| 总资产 | $13.1B | $8.5B |
| 负债/权益比越低杠杆越低 | 0.18× | 0.06× |
8季度趋势，按日历期对齐
现金及短期投资CHRDRMD
| Q4 25 | $189.5M | $1.4B | ||
| Q3 25 | $629.2M | $1.4B | ||
| Q2 25 | $40.5M | $1.2B | ||
| Q1 25 | $35.8M | $932.7M | ||
| Q4 24 | $37.0M | $521.9M | ||
| Q3 24 | $52.0M | $426.4M | ||
| Q2 24 | $197.4M | $238.4M | ||
| Q1 24 | $296.4M | $237.9M |
总债务CHRDRMD
| Q4 25 | $1.5B | $403.9M | ||
| Q3 25 | $1.5B | $408.7M | ||
| Q2 25 | $918.9M | $658.4M | ||
| Q1 25 | $798.8M | $663.1M | ||
| Q4 24 | $842.6M | $662.9M | ||
| Q3 24 | $867.2M | $667.6M | ||
| Q2 24 | $1.0B | $697.3M | ||
| Q1 24 | $396.3M | $997.0M |
股东权益CHRDRMD
| Q4 25 | $8.1B | $6.3B | ||
| Q3 25 | $8.1B | $6.1B | ||
| Q2 25 | $8.1B | $6.0B | ||
| Q1 25 | $8.6B | $5.5B | ||
| Q4 24 | $8.7B | $5.3B | ||
| Q3 24 | $8.8B | $5.2B | ||
| Q2 24 | $8.8B | $4.9B | ||
| Q1 24 | $5.1B | $4.6B |
总资产CHRDRMD
| Q4 25 | $13.1B | $8.5B | ||
| Q3 25 | $13.1B | $8.3B | ||
| Q2 25 | $12.5B | $8.2B | ||
| Q1 25 | $13.1B | $7.6B | ||
| Q4 24 | $13.0B | $7.1B | ||
| Q3 24 | $13.0B | $7.2B | ||
| Q2 24 | $13.1B | $6.9B | ||
| Q1 24 | $7.0B | $6.8B |
负债/权益比CHRDRMD
| Q4 25 | 0.18× | 0.06× | ||
| Q3 25 | 0.18× | 0.07× | ||
| Q2 25 | 0.11× | 0.11× | ||
| Q1 25 | 0.09× | 0.12× | ||
| Q4 24 | 0.10× | 0.13× | ||
| Q3 24 | 0.10× | 0.13× | ||
| Q2 24 | 0.12× | 0.14× | ||
| Q1 24 | 0.08× | 0.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $405.0M | $339.7M |
| 自由现金流经营现金流 - 资本支出 | — | $311.2M |
| 自由现金流率自由现金流/营收 | — | 21.9% |
| 资本支出强度资本支出/营收 | — | 2.0% |
| 现金转化率经营现金流/净利润 | 4.80× | 0.87× |
| 过去12个月自由现金流最近4个季度 | — | $1.8B |
8季度趋势，按日历期对齐
经营现金流CHRDRMD
| Q4 25 | $405.0M | $339.7M | ||
| Q3 25 | $559.0M | $457.3M | ||
| Q2 25 | $419.8M | $538.8M | ||
| Q1 25 | $656.9M | $578.7M | ||
| Q4 24 | $566.5M | $308.6M | ||
| Q3 24 | $663.2M | $325.5M | ||
| Q2 24 | $460.9M | $440.1M | ||
| Q1 24 | $406.7M | $402.0M |
自由现金流CHRDRMD
| Q4 25 | — | $311.2M | ||
| Q3 25 | — | $414.4M | ||
| Q2 25 | — | $508.2M | ||
| Q1 25 | — | $557.9M | ||
| Q4 24 | — | $288.0M | ||
| Q3 24 | — | $307.7M | ||
| Q2 24 | — | $415.2M | ||
| Q1 24 | — | $380.8M |
自由现金流率CHRDRMD
| Q4 25 | — | 21.9% | ||
| Q3 25 | — | 31.0% | ||
| Q2 25 | — | 37.7% | ||
| Q1 25 | — | 43.2% | ||
| Q4 24 | — | 22.5% | ||
| Q3 24 | — | 25.1% | ||
| Q2 24 | — | 33.9% | ||
| Q1 24 | — | 31.8% |
资本支出强度CHRDRMD
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 3.2% | ||
| Q2 25 | — | 2.3% | ||
| Q1 25 | — | 1.6% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 1.5% | ||
| Q2 24 | — | 2.0% | ||
| Q1 24 | — | 1.8% |
现金转化率CHRDRMD
| Q4 25 | 4.80× | 0.87× | ||
| Q3 25 | 4.30× | 1.31× | ||
| Q2 25 | — | 1.42× | ||
| Q1 25 | 2.99× | 1.59× | ||
| Q4 24 | 2.69× | 0.90× | ||
| Q3 24 | 2.94× | 1.05× | ||
| Q2 24 | 2.16× | 1.51× | ||
| Q1 24 | 2.04× | 1.34× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CHRD
| Oil Production | $801.0M | 68% |
| Purchased Oil Sales | $285.8M | 24% |
| Natural Gas And Natural Gas Liquid Services | $75.6M | 6% |
| Purchased Gas Sales | $7.0M | 1% |
RMD
| Sleep And Breathing Health | $1.3B | 88% |
| Residential Care Software | $166.9M | 12% |
